.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for addition of people with MASLD as well as measurement of liver results in cardio-- renal-- metabolic tests, when records advise mechanistically probable perks and clinical security-- and also outlines factors for trial style and also regulatory approval.